title: Expression of the JAK2 V617F mutation is not found in de novo AML and MDS but is detected in MDS-derived leukemia of megakaryoblastic nature.
authors.forename: K
authors.initials: K
authors.lastname: Nishii
authors.forename: R
authors.initials: R
authors.lastname: Nanbu
authors.forename: F
authors.initials: F
authors.lastname: Lorenzo V
authors.forename: F
authors.initials: F
authors.lastname: Monma
authors.forename: K
authors.initials: K
authors.lastname: Kato
authors.forename: H
authors.initials: H
authors.lastname: Ryuu
authors.forename: N
authors.initials: N
authors.lastname: Katayama
mesh_terms: D000208:Acute Disease; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics*; D007947:Leukemia, Megakaryoblastic, Acute / Q000235:genetics*; D007951:Leukemia, Myeloid / Q000235:genetics; D020125:Mutation, Missense; D009190:Myelodysplastic Syndromes / Q000235:genetics
chemical_list: C507924:JAK2 protein, human; D053614:Janus Kinase 2